Single small study · patients with postoperative pain
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Single INR measure · patients with the initiation of oral anticoagulation
It is very uncertain whether 5 mg changes single INR measure compared with 10 mg (very low certainty).
1 finding from 1 review
Pain ‐ 24hrs (Single dose) · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Total Number of Adverse Events ‐ single dose studies · patients with pain management in rheumatoid arthritis
It is very uncertain whether muscle relaxant changes total Number of Adverse Events ‐ single dose studies compared with control (very low certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (single dose regimen) low risk of bias Dienstag 1999 · patients with preventing hepatitis A.
The intervention leads to lower clinically apparent hepatitis A (single dose regimen) low risk of… (high certainty).
1 finding from 1 review
Intervention not reported
Clinically apparent hepatitis A (single dose regimen) all included studies Dienstag 1999 · patients with preventing hepatitis A.
It is very uncertain whether the intervention changes clinically apparent hepatitis A (single dose regimen) all included… (very low certainty).
1 finding from 1 review
Intervention not reported
A time halo effect lasted for 3 days following a single application of enforcement. With 5 days of consecutive enforcement a time halo of at least 6 days was noted. At the site of speed limit enforcement the average speed was reduced to around the...
1 finding from 1 review
no estimate extracted
Studies not reported
High
Intervention not reported
Change in HbA1c from baseline to endpoint ‐ Vildagliptin versus another single hypoglycaemic agent % ( · patients with type 2 diabetes mellitus
1 finding from 1 review
Intervention not reported
Change in HbA1c from baseline to endpoint ‐ Sitagliptin versus another single hypoglycaemic agent % ( · type 2 diabetes mellitus
1 finding from 1 review
Live birth · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes live birth compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Miscarriage · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes miscarriage compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Viable intrauterine Pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes viable intrauterine pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Ectopic pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes ectopic pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Stillbirth · people having preimplantation genetic testing for monogenic/single gene defects
1 finding from 1 review
Termination of pregnancy · people having preimplantation genetic testing for monogenic/single gene defects
It is very uncertain whether day 5 changes termination of pregnancy compared with day 3 embryo biopsy (very low certainty).
1 finding from 1 review
Preterm birth less than 34 weeks' gestation · women with singleton pregnancies at risk of cervical insufficiency
Cervical pessary showed no clear difference in delivery before 34 weeks' gestation compared with no treatment (low certainty).
1 finding from 1 review
Maternal infection or inflammation · women with singleton pregnancies at risk of cervical insufficiency
Cervical pessary showed no clear difference in maternal infection or inflammation compared with vaginal progesterone (moderate certainty).
1 finding from 1 review
Neonatal/paediatric care unit admission · women with singleton pregnancies at risk of cervical insufficiency
Cervical pessary showed no clear difference in neonatal/paediatric care unit admission compared with vaginal progesterone (low certainty).
1 finding from 1 review
Fetal/infant mortality · women with singleton pregnancies at risk of cervical insufficiency
Cervical pessary showed no clear difference in fetal/infant mortality compared with vaginal progesterone (low certainty).
1 finding from 1 review
Harm to offspring from the intervention · women with singleton pregnancies at risk of cervical insufficiency
1 finding from 1 review